ELENA KHLOBYSTOVA: Open Payments
NPI 1831798867 · SOUTHAMPTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,154 in 125 payments from 20 companies in 2025. Trend: 2023 $1,326 · 2024 $2,084 · 2025 $3,154
Food & beverage: $3,154
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 15 | $694 |
| ABBVIE INC. | 35 | $663 |
| Janssen Biotech, Inc. | 10 | $308 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $279 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $265 |
| Aimmune Therapeutics, Inc. | 7 | $147 |
| Braintree Laboratories, Inc. | 4 | $132 |
| Lilly USA, LLC | 6 | $127 |
| GENZYME CORPORATION | 3 | $85 |
| QOL Medical, LLC | 3 | $78 |
Products named: REZDIFFRA, TREMFYA, XIFAXAN, MAVYRET, LINZESS, ENTYVIO, ZENPEP, SUFLAVE.
Industry payments across PA — which companies pay providers there.
